138 related articles for article (PubMed ID: 3734934)
21. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
22. Immune reactivity to native type II collagen in rheumatoid arthritis assessed by the leukocyte adherence inhibition assay and radioimmunoassay.
Tannenbaum H; Clague RB; Holt PJ; Wild J
Clin Invest Med; 1982; 5(4):231-5. PubMed ID: 7160110
[TBL] [Abstract][Full Text] [Related]
23. Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis.
Lorenzo P; Bayliss MT; Heinegård D
Matrix Biol; 2004 Oct; 23(6):381-91. PubMed ID: 15533759
[TBL] [Abstract][Full Text] [Related]
24. Direct degradation of articular cartilage by rheumatoid synovial fluid: contribution of proteolytic enzymes.
Larbre JP; Moore AR; Da Silva JA; Iwamura H; Ioannou Y; Willoughby DA
J Rheumatol; 1994 Oct; 21(10):1796-801. PubMed ID: 7837140
[TBL] [Abstract][Full Text] [Related]
25. Localization and expression of cartilage oligomeric matrix protein by human rheumatoid and osteoarthritic synovium and cartilage.
Di Cesare PE; Fang C; Leslie MP; Della Valle CJ; Gold JM; Tulli H; Perris R; Carlson CS
J Orthop Res; 1999 May; 17(3):437-45. PubMed ID: 10376735
[TBL] [Abstract][Full Text] [Related]
26. Expression of parathyroid hormone-related peptide in human osteoarthritis.
Okano K; Tsukazaki T; Ohtsuru A; Osaki M; Yonekura A; Iwasaki K; Yamashita S
J Orthop Res; 1997 Mar; 15(2):175-80. PubMed ID: 9167618
[TBL] [Abstract][Full Text] [Related]
27. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
28. Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage.
Poole AR; Rosenberg LC; Reiner A; Ionescu M; Bogoch E; Roughley PJ
J Orthop Res; 1996 Sep; 14(5):681-9. PubMed ID: 8893759
[TBL] [Abstract][Full Text] [Related]
29. Removal of hyaline articular cartilage reduces lymphocyte infiltration and activation in rheumatoid synovial membrane.
Konttinen YT; Li TF; Lassus J; Waris V; Santavirta S; Virtanen I
J Rheumatol; 2001 Oct; 28(10):2184-9. PubMed ID: 11669153
[TBL] [Abstract][Full Text] [Related]
30. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
Squires GR; Okouneff S; Ionescu M; Poole AR
Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
[TBL] [Abstract][Full Text] [Related]
32. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
Yasuda T; Poole AR
Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
[TBL] [Abstract][Full Text] [Related]
33. In vitro model of human articular cartilage degradation.
Shingleton WD
Methods Mol Biol; 2003; 225():99-106. PubMed ID: 12769478
[No Abstract] [Full Text] [Related]
34. [Serum keratan sulfate studies and their significance in the evaluation of cartilage degradation in degenerative and inflammatory joint diseases].
Sárközi AM; Hámori G; Fülöp C; Búzás E; Brózik M; Merétey K; Glant TT
Orv Hetil; 1993 Feb; 134(9):461-7. PubMed ID: 8446416
[TBL] [Abstract][Full Text] [Related]
35. Immune pathology in polyarticular osteoarthritis.
Cooke TD
Clin Orthop Relat Res; 1986 Dec; (213):41-9. PubMed ID: 3780105
[TBL] [Abstract][Full Text] [Related]
36. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9.
Cucchiarini M; Thurn T; Weimer A; Kohn D; Terwilliger EF; Madry H
Arthritis Rheum; 2007 Jan; 56(1):158-67. PubMed ID: 17195218
[TBL] [Abstract][Full Text] [Related]
37. Autoimmunity to cartilage link protein in patients with rheumatoid arthritis and ankylosing spondylitis.
Guerassimov A; Zhang Y; Banerjee S; Cartman A; Webber C; Esdaile J; Fitzcharles MA; Poole AR
J Rheumatol; 1998 Aug; 25(8):1480-4. PubMed ID: 9712087
[TBL] [Abstract][Full Text] [Related]
38. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
39. Immunopathologic role of proteoglycan antigens in rheumatoid joint disease.
Glant T; Csongor J; Szücs T
Scand J Immunol; 1980; 11(3):247-52. PubMed ID: 9537052
[TBL] [Abstract][Full Text] [Related]
40. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta.
Kaiser M; Haag J; Söder S; Bau B; Aigner T
Arthritis Rheum; 2004 Nov; 50(11):3535-40. PubMed ID: 15529348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
